What did @claremorrow_ifbbpro actually say?
The claim here is that ibuprofen is quietly sabotaging your gains, your gut, your kidneys, and your liver, and that elite athletes have quietly switched to BPC-157 as a cleaner alternative. The creator calls it "the Wolverine peptide" and says it comes from stomach lining, which regenerates monthly. She implies NFL players actively use it instead of ibuprofen.
A few things to sort out immediately. First, she conflates kidney and liver toxicity, which have different mechanisms with NSAIDs. Second, the NFL claim is presented as established fact, not rumor. Third, the stomach regeneration framing is used to suggest BPC-157 is somehow biologically validated by proximity, which is not how pharmacology works. The muscle-growth angle, though, is not invented, and that part deserves a real look.
Does the science back this up?
The ibuprofen-and-muscle-growth connection has real evidence behind it, though the picture is more complicated than "it stunts growth." The BPC-157 claims, meanwhile, are almost entirely based on animal studies.
On ibuprofen: a 2017 study by Lilja et al. in Acta Physiologica found that high-dose ibuprofen (1200mg/day) significantly blunted muscle hypertrophy and strength gains in young adults doing resistance training over eight weeks, compared to low-dose aspirin. That is a meaningful result. Older research by Trappe et al. (2002, American Journal of Physiology) also found that NSAIDs suppressed muscle protein synthesis after exercise. The mechanism is real: ibuprofen inhibits COX enzymes, which reduces prostaglandin production, and prostaglandins play a role in satellite cell activation after resistance exercise.
On BPC-157: the data does not support the confidence with which it is promoted. Most studies are in rats. A 2018 review by Sikiric et al. in Current Neuropharmacology covers much of the existing research, and it is largely rodent data. There are no large-scale randomized controlled trials in humans demonstrating muscle repair or recovery benefits.
What did they get wrong (or right)?
Credit where it is due: the concern about chronic ibuprofen use and muscle adaptation is not fabricated. The Lilja 2017 data is real, and if you are taking 1200mg of ibuprofen daily while trying to build muscle, that is a legitimate conversation to have with a doctor. The gastrointestinal risk is also well-documented and not controversial.
But here is where the video goes sideways. She says ibuprofen causes "liver problems." Ibuprofen is primarily a kidney stressor, not a liver one. Acetaminophen (Tylenol) is the NSAID-adjacent drug associated with liver toxicity. Conflating these is a common error, but it matters, because it directs people toward the wrong concern about the wrong organ. The NFL claim is presented without any sourcing. And BPC-157 is described as having no "negative side effects," which is not a claim any honest reading of the current literature supports, since we simply do not have enough human safety data to say that.
- Ibuprofen and muscle blunting: mostly accurate, with important dose caveats
- Ibuprofen causing liver damage: inaccurate, kidney is the primary concern
- NFL players using BPC-157: unverifiable, no sourcing provided
- BPC-157 having no negative side effects: unverifiable, insufficient human data
What should you actually know?
If you are training seriously and taking ibuprofen daily for chronic pain or soreness, the muscle-growth concern is worth raising with a sports medicine physician. The evidence suggests that occasional use around workouts is unlikely to cause meaningful harm, but chronic high-dose use is a different story.
BPC-157 is not FDA-approved. It is available as a research compound, and compounded versions exist, but there is no approved human indication, no standardized dosing backed by clinical trials, and no long-term human safety data. Calling it "no negative side effects" because the rat studies look promising is not science, it is marketing. The stomach-regeneration framing is biologically real but logically irrelevant to how the peptide behaves pharmacologically in humans.
If you are over 40 and managing joint pain, recovery, or inflammation, those are legitimate clinical conversations. But they should happen with a licensed provider who can weigh your full picture, not based on an Instagram caption connecting Wolverine to the NFL.